Table 3.
The number of positive lymph nodes and the tumor responses in patients who were treated with neoadjuvant treatment.
| Histopathology of axillary LNs | Recurrence group | Control group |
|---|---|---|
| Negative | 16 (26.67%) | 37 (61.67%) |
| Positive | 44 (73.33%) | 23 (38.33%) |
| Number of positive axillary LNs | ||
| 0 | 17 | 36 |
| 1 | 6 | 7 |
| 2 | 8 | 2 |
| 3 | 7 | 5 |
| 4 | 3 | 2 |
| 5 | 2 | 2 |
| 6 | 5 | 4 |
| 7 | 2 | 0 |
| 8 | 2 | 0 |
| 9 | 3 | 1 |
| 10 | 1 | 0 |
| >10 | 1 | 0 |
| >15 | 1 | 1 |
| >20 | 2 | 0 |
| Pathological response % | ||
| Complete | 8 (13.33%) | 19 (31.67%) |
| 90 | 15 (25.00%) | 11 (18.33%) |
| 80 | 2 (3.33%) | 4 (6.67%) |
| 70 | 3 (5.00%) | 1 (1.67%) |
| 60 | 2 (3.33%) | 2 (3.33%) |
| 50 | 5 (8.33%) | 5 (8.33%) |
| 30 | 0 | 2 (3.33%) |
| 10 | 4 (6.67%) | 3 (5.00%) |
| Unknown | 21 (35.00%) | 13 (21.67%) |
|
| ||
| Total | 60 | 60 |